Advertisement Press Releases Archive - Page 133 of 233 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pressreleases

  • Haselmeier establishes Haselmeier Inc. in the United States

    Haselmeier announced today that it has established a new company in the United States, Haselmeier Inc., a fully owned subsidiary of Haselmeier GmbH. The US is a logical step in our global expansion, say Haselmeier officials, the United States is the largest healthcare market and home to many leading pharmaceutical and biotech companies.

  • Peristaltic Pump Specialist Launches Fully Integrated Drive for OEM Pumps

    Watson-Marlow Pumps Group introduces DriveSure™ its new panel-mount OEM brushless DC gear motor with fully integrated speed controller. DriveSure is highly adaptable, offering 24V and 48V dc options, a 51:1 control ratio between 408-8 rpm, and directly accepts market-standard analogue control signals. With DriveSure, OEM engineers can bring products to market faster and with less engineering cost by eliminating the time, design uncertainty and risks associated with the separate specification of pump motor, gearbox and drive.

  • COPA-DATA begins research project on intelligent user interfaces

    With the rise in the use of modern hardware technology in the industrial environment, such as Smartphones and tablets, there is also an increasing demand for new operating, interaction and visualization concepts. Within the framework of the research project "zenon Smart Interfaces" COPA-DATA is addressing these new market requirements and thereby extending its range of automation solutions for mobile devices.

  • India Regulatory Update

    The Central Drugs Standard Control Organization (CDSCO), the national regulatory body governing pharmaceuticals and medical devices in India, issued draft guidelines earlier this year designed to ensure the quality and identity of pharmaceutical products throughout the distribution process.

  • New EU GDP Guideline

    After almost two years of review, an updated GDP guideline for EU distribution of medicinal products for human use was published in the Official Journal of the European Union on March 7, 2013. This new guideline replaces existing directives (94/C 63/03) that have been in effect since 1994. Compliance with the 2013 EU Guideline (2013/C 68/01) becomes mandatory six months after date of publication, or on September 7, 2013.